Partnerships | Eagles Pharma - Strategic Alliances & Addii Biotech Collaboration

Manufacturer Dialogue Spotlight

Proposed Distribution Collaboration with Addii Biotech Pvt. Ltd., India

Eagles Pharma is actively exploring a strategic distribution partnership with Addii Biotech Pvt. Ltd., India, a reputable pharmaceutical manufacturer recognized for adhering to internationally accepted Good Manufacturing Practice (WHO-GMP) standards.

The ongoing dialogue encompasses the possibility of an exclusive distribution arrangement for the South Sudan market, which would designate Eagles Pharma as the authorized national distributor for Addii Biotech's extensive portfolio of essential therapeutic formulations.

Crucial Regulatory & Contractual Disclosure: Please note that all discussions and potential distribution frameworks with Addii Biotech Pvt. Ltd., India, remain in an exploratory, pre-launch stage. This prospective collaboration is strictly subject to the execution of a final definitive written agreement, formal company incorporation of Eagles Pharma, granting of required pharmaceutical wholesale and import licences, product dossier approvals, and regulatory requirements mandated by the Drug and Food Control Authority (DFCA) of the Republic of South Sudan. No formal binding distribution contracts have been executed to date.

Inquire About Manufacturer Alliances

Manufacturing Partner Profile

Addii Biotech Pvt. Ltd.

New Delhi / Haryana, India

WHO-GMP & ISO Facilities: Modern production lines certified under international quality systems with automated packaging and serialization.

Therapeutic Breadth: Extensive therapeutic portfolio covering antimalarials, broad-spectrum antibiotics, pain management, and chronic disease therapies.

Zone IVb Stability Validation: Medicines tested under accelerated and real-time conditions matching South Sudan's hot and humid tropical profile.

Potential Exclusivity: Discussions exploring sole authorized distribution channel into South Sudan to ensure pricing discipline and eliminate parallel grey imports.

Agreement Status: Exploratory / Pre-Launch

Global Manufacturer Engagement

Why Partner With Eagles Pharma in South Sudan?

Navigating pharmaceutical entry into emerging African markets requires compliance rigour, robust storage infrastructure, and trusted local relationships.

DFCA Registration Management

We handle end-to-end product dossier compilation in CTD format, sample submissions, and regulatory liaison with the Drug and Food Control Authority of South Sudan.

Brand Equity & Anti-Diversion

By establishing closed, audited distribution corridors from manufacturer warehouses to end-point healthcare facilities, we prevent counterfeit infiltration and grey-market leaks.

Institutional Market Demand

Deep connectivity with public health institutions, faith-based hospital networks, and international NGOs operating humanitarian health clusters across South Sudan.

Institutional Collaboration

Frameworks for Hospitals & Humanitarian Responders

Healthcare providers and relief agencies in South Sudan cannot afford supply volatility. Eagles Pharma is formulating institutional partnership frameworks designed to provide security of supply through:

Collaborative Demand Forecasting: Joint annual and quarterly requirement modeling to align manufacturing schedules with seasonal disease spikes (e.g. malaria surges during the rainy season).

Emergency Buffer Stockpiling: Maintained safety stock reserves in Juba for critical trauma, IV fluids, and pediatric antimalarials, insulating facilities from international freight delays.

Compliant Institutional Tendering: Transparent, auditable procurement documentation matching UN, USAID, and European donor accountability criteria.

Partnership Intake

Partnership Enquiry Form

Engage our corporate development team regarding manufacturer, hospital, or institutional collaboration.

Full Contact Name *

Professional Email *

Organization / Enterprise *

Partnership Category *

Scope of Proposed Collaboration *

Notice: All submitted inquiries are handled under corporate confidentiality. Commercial agreements are subject to South Sudan DFCA licensing.